Jean L. Rouleau
About
Jean L. Rouleau is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Jean L. Rouleau has authored 356 papers receiving a total of 44.0k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Cardiology and Cardiovascular Medicine, 55 papers in Surgery and 51 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean L. Rouleau's work include Heart Failure Treatment and Management (208 papers), Cardiovascular Function and Risk Factors (139 papers) and Cardiac pacing and defibrillation studies (56 papers). Jean L. Rouleau is often cited by papers focused on Heart Failure Treatment and Management (208 papers), Cardiovascular Function and Risk Factors (139 papers) and Cardiac pacing and defibrillation studies (56 papers). Jean L. Rouleau collaborates with scholars based in Canada, United States and United Kingdom. Jean L. Rouleau's co-authors include Marc A. Pfeffer, Milton Packer, Scott D. Solomon, Lemuel A. Moyé, John J.V. McMurray, Michael R. Zile, Karl Swedberg, Akshay S. Desai, Barry R. Davis and John D. Rutherford and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.
In The Last Decade
Jean L. Rouleau
345 papers receiving 42.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jean L. Rouleau Canada | 86 | 32.2k | 12.9k | 7.3k | 5.1k | 4.3k | 356 | 44.0k | ||
| Roger S. Blumenthal United States | 98 | 20.5k 0.6× | 12.2k 0.9× | 8.8k 1.2× | 3.6k 0.7× | 10.7k 2.5× | 762 | 44.8k | ||
| Sabina A. Murphy United States | 97 | 30.0k 0.9× | 17.9k 1.4× | 8.1k 1.1× | 2.7k 0.5× | 6.4k 1.5× | 487 | 43.5k | ||
| Marc S. Sabatine United States | 107 | 27.9k 0.9× | 22.8k 1.8× | 13.3k 1.8× | 3.5k 0.7× | 5.2k 1.2× | 512 | 51.0k | ||
| Nanette K. Wenger United States | 75 | 20.5k 0.6× | 10.3k 0.8× | 6.4k 0.9× | 2.0k 0.4× | 5.8k 1.4× | 372 | 35.9k | ||
| J. Wouter Jukema Netherlands | 97 | 14.3k 0.4× | 19.8k 1.5× | 7.5k 1.0× | 3.7k 0.7× | 8.2k 1.9× | 895 | 41.5k | ||
| John A. Spertus United States | 118 | 40.6k 1.3× | 14.9k 1.2× | 8.7k 1.2× | 5.3k 1.0× | 9.1k 2.1× | 1.1k | 67.1k | ||
| Jan A. Staessen Belgium | 102 | 35.5k 1.1× | 7.8k 0.6× | 8.3k 1.1× | 3.9k 0.8× | 1.8k 0.4× | 1.0k | 51.8k | ||
| Aldo P. Maggioni Italy | 107 | 35.8k 1.1× | 8.0k 0.6× | 9.5k 1.3× | 5.4k 1.1× | 4.1k 1.0× | 873 | 49.2k | ||
| Christopher B. Granger United States | 119 | 49.5k 1.5× | 13.8k 1.1× | 4.1k 0.6× | 4.8k 0.9× | 10.0k 2.3× | 846 | 63.9k | ||
| Eugene Braunwald United States | 104 | 43.0k 1.3× | 20.7k 1.6× | 5.6k 0.8× | 3.7k 0.7× | 12.5k 2.9× | 448 | 59.7k |
Countries citing papers authored by Jean L. Rouleau
Since
Specialization
Citations
This map shows the geographic impact of Jean L. Rouleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean L. Rouleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean L. Rouleau more than expected).
Fields of papers citing papers by Jean L. Rouleau
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jean L. Rouleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean L. Rouleau. The network helps show where Jean L. Rouleau may publish in the future.
Co-authorship network of co-authors of Jean L. Rouleau
This figure shows the co-authorship network connecting the top 25 collaborators of Jean L. Rouleau. A scholar is included among the top collaborators of Jean L. Rouleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean L. Rouleau. Jean L. Rouleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kondo, Toru, Pardeep S. Jhund, Inder S. Anand, et al.. (2025). Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF. JACC Heart Failure. 13(6). 927–939.
2.
Ryan, M. J., Mark C. Petrie, Evangelos Kontopantelis, et al.. (2025). Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis. European Heart Journal. 46(22). 2052–2062.
3.
Chatur, Safia, Iris E. Beldhuis, Brian Claggett, et al.. (2024). Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2. JACC Heart Failure. 12(10). 1692–1703.
4.
Lu, Henri, Brian Claggett, Milton Packer, et al.. (2024). Race in Heart Failure. JACC Heart Failure. 13(1). 58–71.
5.
Foà, Alberto, Muthiah Vaduganathan, Brian Claggett, et al.. (2024). Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction. Journal of the American College of Cardiology. 83(18). 1731–1739.
6.
Lu, Henri, Brian Claggett, Milton Packer, et al.. (2024). Visit-to-Visit Changes in Heart Rate in Heart Failure: A Pooled Participant-Level Analysis of the PARADIGM-HF and PARAGON-HF Trials. European Journal of Heart Failure. 27(1). 60–68.
7.
Tolomeo, Paolo, Jawad H. Butt, Toru Kondo, et al.. (2023). Independent Prognostic Importance of Blood Urea Nitrogen to Creatinine Ratio in Heart Failure. European Journal of Heart Failure. 26(2). 245–256.
8.
Jering, Karola, Brian Claggett, Marc A. Pfeffer, et al.. (2023). Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation Heart Failure. 16(5). e010259–e010259.
9.
Leclair, Grégoire, Martin Jutras, Ian Mongrain, et al.. (2023). Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males. Clinical and Translational Science. 16(5). 872–885.
10.
Ehteshami‐Afshar, Solmaz, Leanne Mooney, Pooja Dewan, et al.. (2021). Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF. Journal of the American Heart Association. 10(4). e019238–e019238.
11.
Chandra, Alvin, Eldrin F. Lewis, Brian Claggett, et al.. (2018). Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure. JAMA Cardiology. 3(6). 498–498.
12.
Mogensen, Ulrik M., Pardeep S. Jhund, Lars Køber, et al.. (2016). Abstract 17986: Is There Really an “Obesity Paradox” in Heart Failure? An Analysis of PARADIGM-HF. Circulation.
13.
McMurray, John J.V., Milton Packer, Akshay S. Desai, et al.. (2013). Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF). European Journal of Heart Failure. 15(9). 1062–1073.
14.
Shah, Amil M., Sung‐Hee Shin, Madoka Takeuchi, et al.. (2011). Left Ventricular Systolic and Diastolic Function, Remodelling, and Clinical Outcomes Among Patients with Diabetes Following Myocardial Infarction and the Influence of Direct Renin Inhibition with Aliskiren. European Journal of Heart Failure. 14(2). 185–192.
15.
Rouleau, Jean L., Wayne Warnica, Richard Baillot, et al.. (2007). Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early After Coronary Artery Bypass Surgery. Circulation. 117(1). 24–31.
16.
Stanton, Eric, Mark Hansen, Harindra C. Wijeysundera, et al.. (2004). A Direct Comparison of the Natriuretic Peptides and Their Relationship to Survival in Chronic Heart Failure of a Presumed Non-Ischaemic Origin. European Journal of Heart Failure. 7(4). 557–565.
17.
Lapointe, Nathalie, James N. Tsoporis, Thomas G. Parker, et al.. (2003). Comparative effects of a vasopeptidase inhibitor vs. an angiotensin convertin enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure. Molecular and Cellular Biochemistry. 254(1-2). 235–245.
18.
Cohn, Jay N., Marc A. Pfeffer, Jean L. Rouleau, et al.. (2003). Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON). European Journal of Heart Failure. 5(5). 659–667.
19.
White, Michel, Jean L. Rouleau, Christian Hall, et al.. (2001). Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. American Heart Journal. 142(6). 1056–1064.
20.
Vantrimpont, Pascal & Jean L. Rouleau. (1997). Medical treatment of heart failure: The Canadian Cardiovascular Society's Consensus Conference revisited. Cardiovascular Drugs and Therapy. 10(6). 711–716.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Roger S. Blumenthal Breakdown of academic impact, for papers by Sabina A. Murphy Breakdown of academic impact, for papers by Marc S. Sabatine Breakdown of academic impact, for papers by Nanette K. Wenger Breakdown of academic impact, for papers by J. Wouter Jukema Breakdown of academic impact, for papers by John A. Spertus Breakdown of academic impact, for papers by Jan A. Staessen Breakdown of academic impact, for papers by Aldo P. Maggioni Breakdown of academic impact, for papers by Christopher B. Granger Breakdown of academic impact, for papers by Eugene Braunwald